Mitochondrial dysfunctions in T cells: focus on inflammatory bowel disease
Mitochondria has emerged as a critical ruler of metabolic reprogramming in immune responses and inflammation. In the context of colitogenic T cells and IBD, there has been increasing research interest in the metabolic pathways of glycolysis, pyruvate oxidation, and glutaminolysis. These pathways hav...
Main Authors: | Hoyul Lee, Jae-Han Jeon, Eun Soo Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1219422/full |
Similar Items
-
Curcumin and Inflammatory Bowel Disease: Potential and Limits of Innovative Treatments
by: Liza Vecchi Brumatti, et al.
Published: (2014-12-01) -
The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases
by: Valerio Baldelli, et al.
Published: (2021-03-01) -
The Gut Microbiota in Inflammatory Bowel Disease
by: Peng Qiu, et al.
Published: (2022-02-01) -
The Role of Vitamin D in Immune System and Inflammatory Bowel Disease
by: Wu Z, et al.
Published: (2022-05-01) -
The Multiple Faces of Integrin–ECM Interactions in Inflammatory Bowel Disease
by: Valentina Garlatti, et al.
Published: (2021-09-01)